Adicet Bio Capital Expenditures (CapEx) Growth & History (ACET)

Adicet Bio's capital expenditures (capex) was $1.7M for fiscal 2025.

View full Adicet Bio company overview

Adicet Bio annual capital expenditures (capex) history

Adicet Bio annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$1.7M$620,000+55.46%
20242024-12-31$1.1M−$3.3M−74.96%
20232023-12-31$4.5M−$12.3M−73.40%
20222022-12-31$16.8M$3.7M+28.64%
20212021-12-31$13.0M$12.1M+1217.78%
20202020-12-31$990,000−$80,000−7.48%
20192019-12-31$1.1M$194,000+22.15%
20182018-12-31$876,000$832,000+1890.91%
20172017-12-31$44,000

Adicet Bio capital expenditures (capex) trends

Over the last five fiscal years, Adicet Bio's capital expenditures (capex) increased from $990,000 to $1.7M, a change of $748,000. The latest reported quarter, Q2 2026, shows $202,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Adicet Bio source filings ↗

Community posts

It’s quiet here.

No posts about ACET yet. Start the conversation.

Write the first post